Interleukin-12 in Treating Patients With Cancer in the Abdomen

Completed · Phase 1

Conditions studied: Anal Cancer, Colorectal Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer

In brief

RATIONALE: Interleukin-12 may kill tumor cells by stimulating a person's white blood cells to kill cancer cells. PURPOSE: Phase I trial to study the effectiveness of interleukin-12 in treating patients with cancer in the abdomen.

Key facts

Study ID

NCT00003046

Run by

M.D. Anderson Cancer Center

People needed

29

Starts

1997-08-01

Expected to finish

2001-10-01

Last updated by the study team

2012-07-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Texas - MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.